南方医药创新股票A(010592)利润分配表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
收入 |
-189,512,327.70 |
-172,861,873.06 |
-147,145,706.42 |
-81,819,648.98 |
利息合计 |
1,523,435.98 |
837,474.58 |
1,349,219.84 |
774,669.55 |
其中:存款利息收入 |
750,459.35 |
385,198.26 |
1,048,466.55 |
760,309.45 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
772,976.63 |
452,276.32 |
300,753.29 |
14,360.10 |
投资收益合计 |
-137,664,467.57 |
-151,221,935.70 |
-387,469,354.02 |
-294,771,485.48 |
其中:股票投资收益 |
-158,521,985.38 |
-166,018,110.20 |
-407,031,697.50 |
-307,514,842.81 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
1,630,195.53 |
813,578.15 |
3,967,790.75 |
912,583.58 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
19,227,322.28 |
13,982,596.35 |
15,594,552.73 |
11,830,773.75 |
基金分红收益收益 |
- |
- |
- |
- |
公允价值变动收益 |
-53,563,453.04 |
-22,561,208.75 |
238,716,817.39 |
212,015,730.62 |
其他收入 |
192,156.93 |
83,796.81 |
257,610.37 |
161,436.33 |
费用 |
27,577,578.93 |
14,222,446.22 |
38,028,825.19 |
21,961,285.60 |
管理人报酬 |
20,480,825.29 |
10,545,746.85 |
28,635,231.66 |
16,718,051.95 |
基金托管费 |
3,413,470.78 |
1,757,624.44 |
4,772,538.53 |
2,786,341.95 |
销售服务费 |
3,436,206.55 |
1,778,285.69 |
4,324,360.04 |
2,305,363.31 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
247,075.31 |
140,789.24 |
296,684.06 |
151,526.66 |
利润总额 |
-217,089,906.63 |
-187,084,319.28 |
-185,174,531.61 |
-103,780,934.58 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年